1-(4-(1H-Indol-3-yl)piperidin-1-yl)ethanone

Catalog No. :
ACGAVT680
CAS No. :
30030-83-2
Molecular Formula :
C15H18N2O
Molecular Weight :
242.32

IUPAC Name:1-(4-(1H-indol-3-yl)piperidin-1-yl)ethan-1-one

1-(4-(1H-Indol-3-yl)piperidin-1-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$352.00Login to see priceInquiryInquiry
1g97%$645.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(1H-Indol-3-yl)piperidin-1-yl)ethanone
IUPAC Name1-(4-(1H-indol-3-yl)piperidin-1-yl)ethan-1-one
MDL No.MFCD01764639
Molecular FormulaC15H18N2O
Molecular Weight242.32
SMILESCC(N1CCC(C2=CNC3=C2C=CC=C3)CC1)=O
InChI KeyPRFIVCWVSORYRV-UHFFFAOYSA-N
Synonym1-[4-(1H-INDOL-3-YL)PIPERIDINO]ETHAN-1-ONE;1-[4-(1H-Indol-3-yl)piperidin-1-yl]ethan-1-one;1-Acetyl-4-(1H-indol-3-yl)piperidine, 3-(1-Acetylpiperidin-4-yl)-1H-indole;1-(4-(1H-Indol-3-yl)piperidin-1-yl)ethanone;Ethanone, 1-[4-(1H-indol-3-yl)-1-piperidinyl]-
CAS No.30030-83-2
PubChem CID2728359

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGAVT680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGAVT680 route product structure diagram
    ACGAVT68030030-83-2
Inquiry

2. ACGAVT680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBVOL263 route compound structure diagram
    ACBVOL26317403-09-7 In Stock
  4. Then
  5. ACGAVT680 route product structure diagram
    ACGAVT68030030-83-2
Inquiry

Comments (0)